ATE355059T1 - Isoxazolopyridinone - Google Patents

Isoxazolopyridinone

Info

Publication number
ATE355059T1
ATE355059T1 AT02772157T AT02772157T ATE355059T1 AT E355059 T1 ATE355059 T1 AT E355059T1 AT 02772157 T AT02772157 T AT 02772157T AT 02772157 T AT02772157 T AT 02772157T AT E355059 T1 ATE355059 T1 AT E355059T1
Authority
AT
Austria
Prior art keywords
isoxazolopyridinones
Prior art date
Application number
AT02772157T
Other languages
English (en)
Inventor
Samuel Hintermann
Bastian Hengerer
Krosigk Ulrike Von
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE355059T1 publication Critical patent/ATE355059T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT02772157T 2001-08-15 2002-08-14 Isoxazolopyridinone ATE355059T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0119911.6A GB0119911D0 (en) 2001-08-15 2001-08-15 Organic Compounds

Publications (1)

Publication Number Publication Date
ATE355059T1 true ATE355059T1 (de) 2006-03-15

Family

ID=9920454

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02772157T ATE355059T1 (de) 2001-08-15 2002-08-14 Isoxazolopyridinone

Country Status (24)

Country Link
US (1) US7087756B2 (de)
EP (1) EP1418912B1 (de)
JP (1) JP2005501847A (de)
KR (1) KR20040029429A (de)
CN (1) CN100384418C (de)
AR (1) AR036351A1 (de)
AT (1) ATE355059T1 (de)
BR (1) BR0211903A (de)
CA (1) CA2454762A1 (de)
CO (1) CO5560566A2 (de)
DE (1) DE60218484T2 (de)
EC (1) ECSP044971A (de)
ES (1) ES2282467T3 (de)
GB (1) GB0119911D0 (de)
HU (1) HUP0401325A3 (de)
IL (1) IL160018A0 (de)
MX (1) MXPA04001419A (de)
NO (1) NO20040659L (de)
PE (1) PE20030356A1 (de)
PL (1) PL366848A1 (de)
PT (1) PT1418912E (de)
RU (1) RU2004107847A (de)
WO (1) WO2003015780A2 (de)
ZA (1) ZA200400525B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2002102807A1 (ja) * 2001-06-14 2004-09-30 萬有製薬株式会社 新規イソキサゾロピリドン誘導体及びその用途
AU2005245411B2 (en) * 2004-05-14 2009-04-23 Irm Llc Compounds and compositions as PPAR modulators
CN101466380A (zh) * 2006-02-16 2009-06-24 麦克莱恩医院 治疗帕金森病的方法和组合物
AU2007275301A1 (en) 2006-07-20 2008-01-24 Amgen Inc. Substituted azole aromatic heterocycles as inhibitors of 11-beta-HSD-1
FR2906250B1 (fr) * 2006-09-22 2008-10-31 Sanofi Aventis Sa Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique
FR2933609B1 (fr) * 2008-07-10 2010-08-27 Fournier Lab Sa Utilisation de derives d'indole comme activateurs de nurr-1, pour le traitement de la maladie de parkinson.
WO2010083218A1 (en) 2009-01-13 2010-07-22 Van Andel Research Institute Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids
FR2950053B1 (fr) 2009-09-11 2014-08-01 Fournier Lab Sa Utilisation de derives d'indole benzoique comme activateurs de nurr-1, pour le traitement de la maladie de parkinson
FR2955110A1 (fr) 2010-01-08 2011-07-15 Fournier Lab Sa Nouveaux derives de type pyrrolopyridine benzoique
DE102011085038A1 (de) 2011-10-21 2013-04-25 Tesa Se Verfahren zur Kapselung einer elektronischen Anordnung
AU2014324961A1 (en) 2013-09-25 2016-04-14 Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences Highly potent glucocorticoids
KR20170033630A (ko) 2015-09-17 2017-03-27 (주)다올 도로용 경계블럭
WO2018071736A1 (en) 2016-10-14 2018-04-19 Van Andel Research Institute Structures and mechanism for the design of highly potent glucocorticoids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7602542L (sv) 1975-03-14 1976-09-15 Sandoz Ag 3-(alfa-iminobensyl)-4-hydroxi-2(lh)-pyridoner
US4064251A (en) * 1976-06-25 1977-12-20 Sandoz, Inc. Substituted hydroxy pyridones
US4049813A (en) * 1976-07-15 1977-09-20 Sandoz, Inc. Substituted isoxazolo pyridinones
US4238616A (en) * 1977-01-19 1980-12-09 Sandoz, Inc. 3-(Substituted)phenyl-5-(β-hydroxyphenethyl)-N-(alkyl)-isoxazole-4-carboxamides
DE2801190A1 (de) * 1977-01-19 1978-07-20 Sandoz Ag 3-(alpha-iminobenzyl)-4-hydroxy-2(1h)- pyridon-derivat
US4113727A (en) * 1977-04-26 1978-09-12 Sandoz, Inc. Process for the preparation of substituted isoxazolo[4,5-c]pyridin-4-(5H)-ones
JPWO2002102807A1 (ja) * 2001-06-14 2004-09-30 萬有製薬株式会社 新規イソキサゾロピリドン誘導体及びその用途

Also Published As

Publication number Publication date
NO20040659D0 (no) 2004-02-13
HUP0401325A2 (hu) 2004-10-28
EP1418912B1 (de) 2007-02-28
IL160018A0 (en) 2004-06-20
EP1418912A2 (de) 2004-05-19
DE60218484T2 (de) 2007-11-15
MXPA04001419A (es) 2004-05-27
NO20040659L (no) 2004-02-13
CO5560566A2 (es) 2005-09-30
PT1418912E (pt) 2007-05-31
GB0119911D0 (en) 2001-10-10
ZA200400525B (en) 2005-04-01
AR036351A1 (es) 2004-09-01
DE60218484D1 (de) 2007-04-12
PE20030356A1 (es) 2003-05-14
WO2003015780A3 (en) 2003-11-13
CN100384418C (zh) 2008-04-30
WO2003015780A8 (en) 2004-05-21
CN1635889A (zh) 2005-07-06
WO2003015780A2 (en) 2003-02-27
HUP0401325A3 (en) 2005-09-28
RU2004107847A (ru) 2005-05-10
BR0211903A (pt) 2004-09-21
US7087756B2 (en) 2006-08-08
KR20040029429A (ko) 2004-04-06
JP2005501847A (ja) 2005-01-20
CA2454762A1 (en) 2003-02-27
PL366848A1 (en) 2005-02-07
ECSP044971A (es) 2004-03-23
ES2282467T3 (es) 2007-10-16
US20040248893A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
DE50204184D1 (de) Espressobrüheinrichtung
ATE524462T1 (de) C5-modifizierte indazolylpyrrolotriazine
DE50214313D1 (de) Koaxialmagentventil
DE50103741D1 (de) Welle-Nabe-Verbindung
DE50206021D1 (de) Schlauchklemme
DE50208022D1 (de) Wischblatt
DE50212173D1 (de) sgängern
DE50204386D1 (de) Kreuztransducer
DE50209238D1 (de) Kugelgelenk
DE50204551D1 (de) Kugelgelenk
ATE335486T1 (de) Hydrazono-malonitrile
DE50211604D1 (de) Chlag
DE50208372D1 (de) Schrankaufhängevorrichtung
DE50204794D1 (de) Kugelgelenk
DE50211290D1 (de) Handzange
DE50203412D1 (de) Schwenkkolbenverdränger
DE50203984D1 (de) Kugelgelenk
DE50208029D1 (de) Kugelgelenk
DE60218484D1 (de) Isoxazolopyridinone
DE50201862D1 (de) Messwandler
DE50203093D1 (de) Losradlager
ATA18372001A (de) Gelenksbolzenbaueinheit
ATE319694T1 (de) Phenylalkyne
DE50209293D1 (de) Amidpolymermasse
DE50202088D1 (de) Garmodulsystem

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1418912

Country of ref document: EP

REN Ceased due to non-payment of the annual fee